Interestingly, while TILs seemed not to correlate with response and survival outcomes in a pan-cancer context, PD-L1% was positively associated with a slightly higher likelihood of achieving an objective response (OR: 1.03) and a 1% reduction in the risk of progression or death for each unitary increase. This evidence concerns the gene CD274 and cancer.